William Blair & Company

Baker Tilly Secures Strategic Investment Led by Hellman & Friedman

Retrieved on: 
Monday, February 5, 2024

Leading advisory CPA firm Baker Tilly US, LLP (“Baker Tilly”) today announces a strategic investment from private equity firms Hellman & Friedman (“H&F”) and Valeas Capital Partners (“Valeas”).

Key Points: 
  • Leading advisory CPA firm Baker Tilly US, LLP (“Baker Tilly”) today announces a strategic investment from private equity firms Hellman & Friedman (“H&F”) and Valeas Capital Partners (“Valeas”).
  • The investment, estimated to close in early June 2024, recognizes Baker Tilly’s outstanding track record of value creation and marks the largest private equity investment in the US CPA sector to date.
  • Baker Tilly US, LLP will operate as a separate legal entity pursuant to regulatory and independence requirements.
  • Following the restructuring, both firms will remain partnerships, with all partners holding equity alongside H&F and Valeas in Baker Tilly Advisory Group, LP.

Compass Diversified Completes Partnership with Leading “Better-for-You” Feminine Care Brand The Honey Pot Company

Retrieved on: 
Thursday, February 1, 2024

WESTPORT, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, today announced the completion of the Company’s previously announced partnership with The Honey Pot Company, LLC (“The Honey Pot Co.”), pursuant to an agreement entered into on January 14, 2024.

Key Points: 
  • WESTPORT, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, today announced the completion of the Company’s previously announced partnership with The Honey Pot Company, LLC (“The Honey Pot Co.”), pursuant to an agreement entered into on January 14, 2024.
  • Today, The Honey Pot Co. provides a complete feminine care system – powered by plant-derived ingredients and clinically tested formulas – with a diverse set of products across the feminine hygiene, menstrual, consumer health and sexual wellness categories.
  • The Honey Pot Co.’s co-founders and management team invested alongside CODI and will retain a significant minority stake in the business.
  • “We are excited to have completed our partnership with The Honey Pot Co. and look forward to working with Beatrice and her talented team,” said Elias Sabo, CEO of Compass Diversified.

Alto Neuroscience Announces Pricing of Upsized Initial Public Offering

Retrieved on: 
Friday, February 2, 2024

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the pricing of its upsized initial public offering of 8,040,000 shares of common stock at a public offering price of $16.00 per share.

Key Points: 
  • Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the pricing of its upsized initial public offering of 8,040,000 shares of common stock at a public offering price of $16.00 per share.
  • The aggregate gross proceeds to Alto from the offering are expected to be approximately $128.6 million before deducting underwriting discounts and commissions and other offering expenses payable by Alto.
  • In addition, Alto has granted the underwriters a 30-day option to purchase up to an additional 1,206,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
  • Jefferies, TD Cowen, Stifel and William Blair are acting as joint book-running managers for the offering.

H.I.G. Capital Announces the Sale of Cardinal Logistics

Retrieved on: 
Thursday, February 1, 2024

Capital (“H.I.G.”), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce the sale of its portfolio company, Cardinal Logistics (“Cardinal” or the “Company”), to Ryder System, Inc. (“Ryder”) (NYSE: R).

Key Points: 
  • Capital (“H.I.G.”), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce the sale of its portfolio company, Cardinal Logistics (“Cardinal” or the “Company”), to Ryder System, Inc. (“Ryder”) (NYSE: R).
  • Founded in 1997 and headquartered in Concord, NC, Cardinal provides fully outsourced transportation and logistics solutions to customers across diverse end markets.
  • Cardinal enhances operating efficiencies and delivers exceptional service to its customer base.
  • Tom Hostetler, Cardinal’s CEO, said, “We appreciate H.I.G.’s value-added partnership and investment in Cardinal.

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

Retrieved on: 
Monday, January 29, 2024

The transaction, which has been unanimously approved by Science 37 Board of Directors, is valued at an equity value of approximately $38 million and will be structured as an all-cash tender offer to acquire all outstanding shares of Science 37.

Key Points: 
  • The transaction, which has been unanimously approved by Science 37 Board of Directors, is valued at an equity value of approximately $38 million and will be structured as an all-cash tender offer to acquire all outstanding shares of Science 37.
  • “After an extensive review of opportunities available to Science 37, we believe that eMed provides the greatest value to our stockholders, customers, patients, and employees” said David Coman, Chief Executive Officer at Science 37.
  • Upon completion of the transaction, Science 37 will become a privately held company and shares of Science 37 common stock will no longer be listed on any public market.
  • is serving as exclusive financial advisor to Science 37, and Thompson Hine LLP is serving as legal advisor.

Warburg Pincus and TA Associates Enter into an Agreement to Sell Procare Solutions to Roper Technologies

Retrieved on: 
Thursday, January 25, 2024

NEW YORK, Jan. 25, 2024 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the signing of a definitive agreement to sell Procare Solutions ("Procare"), a leading provider of integrated child care center management software and payments processing, to Roper Technologies, Inc. ("Roper") (Nasdaq: ROP), for a total enterprise value of $1.86 billion. TA Associates ("TA"), a leading global private equity firm, also sold its minority interest in Procare as part of the transaction.

Key Points: 
  • TA Associates ("TA"), a leading global private equity firm, also sold its minority interest in Procare as part of the transaction.
  • Procare provides a broad, high-quality product suite that serves the unique and complex demands of more than 37,000 child care centers.
  • Founded in 1992, Procare is a true end-to-end solution that supports customers of all sizes, from single-center operations to complex nationwide enterprises.
  • William Blair & Company, LLC served as lead financial advisor and Raymond James & Associates, Inc. served as an advisor to Warburg Pincus.

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Retrieved on: 
Friday, January 19, 2024

The public offering price for each unit is $1.50 and the public offering price for each pre-funded unit is $1.49.

Key Points: 
  • The public offering price for each unit is $1.50 and the public offering price for each pre-funded unit is $1.49.
  • The public offering is expected to close on or about January 23, 2024, subject to the satisfaction of customary closing conditions.
  • 333-276031) relating to the public offering was declared effective by the Securities and Exchange Commission (the "SEC") on January 19, 2024.
  • Copies of the final prospectus relating to the public offering, may be obtained, when available, from: William Blair & Company, L.L.C.

Compass Diversified Announces Partnership with The Honey Pot Company

Retrieved on: 
Tuesday, January 16, 2024

The Honey Pot Co. will continue to be led by its current leadership team, and existing owners and management will retain a significant minority stake in the company.

Key Points: 
  • The Honey Pot Co. will continue to be led by its current leadership team, and existing owners and management will retain a significant minority stake in the company.
  • The Honey Pot Co.'s disruptive stance is not just about selling products; it is a movement to empower consumers to embrace their bodies and overall well-being.
  • Perella Weinberg Partners served as exclusive financial advisor and Winston & Strawn LLP acted as legal counsel to The Honey Pot Co., while Gibson, Dunn & Crutcher LLP represented The Honey Pot Co.’s management.
  • William Blair & Company acted as exclusive financial advisor and Ropes & Gray LLP acted as legal counsel to Compass Diversified.

Pinstripes Completes Business Combination with Banyan Acquisition Corporation and Will Begin Trading on New York Stock Exchange

Retrieved on: 
Friday, December 29, 2023

Pursuant to the Business Combination, Pinstripes has become a wholly-owned subsidiary of Banyan, which has changed its name to Pinstripes Holdings, Inc. (together with Pinstripes, Inc, “Pinstripes”).

Key Points: 
  • Pursuant to the Business Combination, Pinstripes has become a wholly-owned subsidiary of Banyan, which has changed its name to Pinstripes Holdings, Inc. (together with Pinstripes, Inc, “Pinstripes”).
  • Pinstripes’ Class A common stock and warrants will begin trading on NYSE under the ticker symbols “PNST” and “PNST WS,” respectively, on January 2, 2024.
  • In connection with the Business Combination, Pinstripes has raised more than $70 million in gross proceeds to support the Company’s strategic growth plans and the opening of additional locations.
  • Completing our business combination with Banyan and introducing Pinstripes to the public markets is a tremendous achievement and the next chapter in our business journey,” said Mr. Schwartz.

Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement

Retrieved on: 
Friday, December 1, 2023

The total gross proceeds of the public offering were approximately $143.8 million, before deducting underwriting discounts and commissions and offering expenses payable by Verve.

Key Points: 
  • The total gross proceeds of the public offering were approximately $143.8 million, before deducting underwriting discounts and commissions and offering expenses payable by Verve.
  • All of the shares in the public offering were sold by Verve.
  • In addition, Verve today announced the closing of its previously announced private placement of 2,296,317 shares of its common stock to Eli Lilly and Company, at a price per share equal to the public offering price.
  • Jefferies, Guggenheim Securities, William Blair, BMO Capital Markets, and RBC Capital Markets acted as joint book-running managers for the public offering.